Kolonn to introduce Chiesi's respiratory medicines

Kolon Pharm and Chiesi Farmaceutici S.p.A. in Italy has recently signed a distirbution agreement to release Chiesi's five respiratory drugs including Foster Formoterol Modulite, an HFA-based pressurised metered-dose inhaler (pMDI) product, in Korea.

Under the agreement, Kolon will have promotion, sales and distribution rights for the five products for treatment of asthma and rhinitis, follow...